SummitTX Capital L.P. Takes $706,000 Position in Cigna Group $CI

SummitTX Capital L.P. acquired a new position in shares of Cigna Group (NYSE:CI) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 2,647 shares of the health services provider’s stock, valued at approximately $706,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CI. Cary Street Partners Investment Advisory LLC raised its stake in shares of Cigna Group by 11.0% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after purchasing an additional 36 shares in the last quarter. OLD National Bancorp IN lifted its holdings in Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after purchasing an additional 37 shares during the period. IHT Wealth Management LLC grew its position in Cigna Group by 2.5% in the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock valued at $423,000 after buying an additional 38 shares in the last quarter. Whetstone Capital Advisors LLC increased its stake in Cigna Group by 4.9% during the 4th quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock valued at $228,000 after buying an additional 39 shares during the period. Finally, CYBER HORNET ETFs LLC raised its position in shares of Cigna Group by 5.3% during the 4th quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock worth $220,000 after buying an additional 40 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

Insider Activity at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

CI has been the subject of a number of research analyst reports. The Goldman Sachs Group upped their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, June 20th. Barclays cut Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their target price for the stock from $310.00 to $304.00 in a report on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. Finally, Mizuho lifted their price target on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Cigna Group Price Performance

Shares of NYSE CI opened at $287.56 on Friday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm has a 50-day moving average of $286.75 and a two-hundred day moving average of $281.12. The company has a market capitalization of $76.07 billion, a price-to-earnings ratio of 12.19, a PEG ratio of 1.14 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter in the previous year, the company posted $7.20 EPS. The business’s revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, analysts expect that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is 26.45%.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported second-quarter adjusted earnings of $7.78 per share, above the roughly $7.58–$7.60 analyst consensus and up from $7.20 a year earlier. Total revenue rose 7% year over year to approximately $71.7 billion. Cigna Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its 2026 adjusted income-from-operations outlook to at least $30.45 per share, modestly above the previous outlook and analyst expectations. Growth across both Cigna Healthcare and Evernorth Health Services supported the increase. Cigna raises annual profit forecast
• Positive Sentiment: Cigna Healthcare adjusted revenue increased 9%, while Evernorth revenue rose 6%, indicating broad-based operating momentum. The company also repurchased about $250 million of stock year to date through July 29. The Cigna Group Reports Strong Second Quarter 2026 Results
• Neutral Sentiment: Cigna posted quarterly net income of nearly $1.7 billion, or $6.29 per share, but reported revenue slightly below the consensus estimate in some measures, highlighting the importance of adjusted results and segment growth.
• Negative Sentiment: Investors remain concerned about elevated pharmacy costs and management’s expectation for slower growth in prescriptions for popular GLP-1 drugs, which could limit near-term benefit from the fast-growing treatment category. Cigna Expects Lower Growth in GLP-1 Prescriptions
• Negative Sentiment: Reported data also shows significant insider selling during the past six months, including sales by Chairman and CEO David Cordani. While these transactions may reflect personal portfolio decisions, they can weigh on investor sentiment.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.